Expert guidance and insights to solve your biggest challenges
The challenge: Profit volatility is the new normal
Raw material spikes, energy swings, and demand shocks have turned margin predictability into a relic of the past. Yet many finance teams remain stuck with static annual plans, Excel-heavy processes, and disconnected ERP/EPM systems. By the time insights surface, the window to act has already closed.
The real problem? Finance is still reporting performance rather than architecting it in real time.
Expert insight: Shift from hindsight to performance architecture
Leading CFOs are evolving into Enterprise Performance Architects, connecting operational drivers (volume, yield, energy, logistics) directly to EBITDA, and using AI-augmented EPM to explain, predict, and simulate decisions in seconds.
Take the example of a global chemical leader operating across three continents. Hampered by legacy tools, fragmented data traceability, and rigid scenario planning, its budgeting cycles were slow, manual, and error-prone. System silos between ERP and legacy platforms created operational bottlenecks.
By adopting a unified budget architecture with automated rule engines and seamless ERP integration, this manufacturer achieved over 80% efficiency gains, real-time scenario modeling, and enterprise-wide alignment. What once took weeks of manual reconciliation now runs on dynamic, driver-based workflows.

Your path forward
Volatile manufacturing markets demand a new finance operating model. WithEVOX AI-augmented EPM and a performance-architect mindset, you can protect EBITDA, simulate trade-offs instantly, and turn uncertainty into strategic advantage.
Profit volatility doesn’t have to be a threat. Architect it as your edge.
Tony Lai is the General Manager of EVOX Platform, where he works with finance leaders across industries to improve strategic planning, forecasting, and enterprise performance management. He frequently collaborates with CFOs and FP&A teams in life sciences organizations to strengthen financial visibility across complex R&D portfolios.
